Bortezomib
Takeda
['dlbcl', 'borte', 'lymphoma', ' abc,(- abcsg)', 'bortezomib', ' ipi ', 'illumina']
congress | #ash22 andrew davies, presents a retrospective analysis using a gene expression-based classifier and final results from the phase iii remodl-b trial. gene expression profiling can identify subtypes of #dlbcl which may benefit from rb-chop in initial therapy. 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm